B淋巴瘤細(xì)胞B-lymphoma cells懸浮細(xì)胞如何固定免疫刺激解決方案?
B-lymphoma cells懸浮細(xì)胞,B細(xì)胞淋巴瘤是B細(xì)胞發(fā)生的實(shí)體腫瘤。包括霍奇金淋巴瘤和非霍奇金淋巴瘤。B細(xì)胞淋巴腫瘤是一種起源于B淋巴細(xì)胞的惡性腫瘤,也被稱(chēng)為非霍奇金淋巴瘤(NHL)。它是淋巴瘤的一種常見(jiàn)類(lèi)型,約占所有淋巴瘤的30-40%。B細(xì)胞淋巴腫瘤的特點(diǎn)是異常B細(xì)胞在淋巴結(jié)或其他器官中異常增生,并可能影響患者的免疫功能。
研究懸浮細(xì)胞時(shí),我們經(jīng)常需要做免疫熒光,但是懸浮細(xì)胞如何固定?一直困擾著我們。如何像貼壁細(xì)胞一樣處理懸浮細(xì)胞,避免掉片或者細(xì)胞固定不住,痛點(diǎn)解決方案來(lái)了。靶點(diǎn)科技Shi-Fix coverslips可以固定懸浮細(xì)胞,僅僅需要四步。
B-lymphoma cells如何固定?并且固定還可以刺激培養(yǎng),可以參考如下解決方案。
Evaluation of cellular uptake of gold nanoparticles under a confocal microscope
B-lymphoma cells (5?×?105 cells/mL) were seeded in Shi-fix coverslips (Shikhar Biotech) and incubated in RPMI 1640 medium supplied with 10% FBS under a 5% CO2 atmosphere. After 24?h of incubation, the cells were washed twice with PBS and treated with FITC-labeled NK20a peptide (NK20a-FITC) or NK20a-FITC@Au nanoparticles for 1?h at 37?°C. For visualization, the cell membranes were stained with Cytopainter (ab219942, Abcam, Cambridge, UK), and the nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI). The samples were each treated with 100?µL of Cytopainter for 20?min, then washed with fresh PBS. Subsequently, the cells were fixed with 4% glutaraldehyde for another 20?min. After the fixation, 3–4 drops of mounting medium with 0.0002% DAPI (ab104139, Abcam, Cambridge, UK) were applied directly to the samples to stain the nuclei of cells. The prepared samples were imaged with a confocal fluorescence microscope (C2si?+?, Nikon, Tokyo, Japan).
相關(guān)產(chǎn)品
免責(zé)聲明
- 凡本網(wǎng)注明“來(lái)源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來(lái)源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其他來(lái)源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點(diǎn)和對(duì)其真實(shí)性負(fù)責(zé),不承擔(dān)此類(lèi)作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí),必須保留本網(wǎng)注明的作品第一來(lái)源,并自負(fù)版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問(wèn)題,請(qǐng)?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。